Related Experiment Video
Updated: Dec 30, 2025
09:09
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
1.4K
Calculated decisions: Shock index, pediatric age-adjusted (SIPA)
1Department of Primary Care, Touro College of Osteopathic Medicine, Middletown, NY
Pediatric Emergency Medicine Practice
|January 25, 2020
Summary
The age-adjusted Shock Index in Pediatric Age (SIPA) accurately predicts mortality in children. This tool aids in early identification of critically ill pediatric patients.
Area of Science:
- Pediatric critical care medicine
- Clinical prediction tools
- Biostatistics in pediatrics
Background:
- Pediatric mortality remains a significant global health concern.
- Accurate and timely risk stratification is crucial for effective pediatric emergency care.
- Existing mortality prediction models may not adequately account for age-specific physiological variations in children.
Purpose of the Study:
- To introduce and validate the Shock Index in Pediatric Age (SIPA) as a novel tool for predicting mortality in pediatric patients.
- To assess the performance of SIPA in identifying children at high risk of death.
Main Methods:
- Development of the SIPA score, incorporating age-adjustment into the traditional shock index calculation.
- Retrospective analysis of pediatric patient data, including vital signs and outcomes.
- Statistical validation of SIPA's predictive accuracy for mortality.
Main Results:
- The age-adjusted Shock Index in Pediatric Age (SIPA) demonstrated significant predictive power for pediatric mortality.
- SIPA effectively differentiated between children with varying mortality risks.
- Age-adjustment improved the precision of the shock index in pediatric populations.
Conclusions:
- The SIPA is a valuable, age-specific clinical tool for predicting mortality in children.
- Implementing SIPA can enhance early risk assessment and potentially improve outcomes in pediatric critical care.
- Further prospective studies are warranted to confirm SIPA's utility in diverse clinical settings.
Related Concept Videos
01:29Drug Dosing: Infants and Children
195
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
195
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
205
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
345
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
345
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
186
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
01:17z Scores and Area Under the Curve
17.9K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
17.9K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
160
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160